Compound ID | 1842
Class: Aminoglycoside
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. Active against Gram-positive and Gram-negative bacteria |
| Description: | Streptomyces natural product. Veterinary use, rarely used in human medicine (e.g. Neisseria gonorrhoeae) |
| Year first mentioned: | 1961 |
| Highest developmental phase: | Approved by FDA in 1971 |
| Development status: | Approved, off-patent |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/15541 |
| Guide to Pharmacology: | spectinomycin |
| Citation: | https://pubmed.ncbi.nlm.nih.gov/13867836/ |